Takeda to Cut 4,500 Jobs in Fiscal 2026 Restructuring
Takeda Pharmaceutical will cut 4,500 jobs in fiscal 2026 to centralize functions and cut costs. The firm targets annual savings of 200 billion yen by 2028.
Xurve View
Insights:
Xurve View
TAKEDA PHARMACEUTICAL CO LTD will cut 4,500 jobs by the end of fiscal 2026 to centralize corporate functions and reduce costs. The restructuring follows debt and complexity from its $62 billion acquisition of Shire in 2019. Investors are monitoring the drugmaker's ability to generate 200 billion yen ($1.27 billion) in annual savings by fiscal 2028.
